Sentence examples for advantage loss from inspiring English sources

Interestingly while overexpression confers a growth advantage, loss enhances sensitivity to DNA damaging agents.

There are at least three means to achieve this survival advantage: loss of netrin-1 receptors expression, as extensively described in human colorectal cancer for DCC or/and UNC5H (Bernet et al, 2007; Fearon et al, 1990; Shin et al, 2007; Thiebault et al, 2003); loss of downstream death signalling induced by DCC or UNC5H; or gain of autocrine or paracrine expression of the ligand.

In contrast to concerns raised by pharmaceutical companies regarding competitive advantage losses, interviewees highlighted gains in reputation and credibility due to improved transparency.

By taking advantage of loss offsets, tax payers can use underperforming investments to shrink their tax rate--in some cases to zero:My uninformed-by-ever-having-been-a-tax-lawyer sense is that loss offsets for the capital gains tax are worth a great deal to some investors.

It is seen that at the frequencies above 1 kHz, the core made of the ribbon with transverse anisotropy (heated by current under tensile stress) show a significant advantage in loss as compared to cut core.

Taking into account that DC bias does not exceed 1 kA/m under commonly used conditions of core exploitation, we can state that new core (made of the ribbon crystallized under application of tensile stress 180 MPa) have significant advantage by loss level over cut cores made of the same Fe73Nb3Cu1B7Si16 alloy.

The diversity of deletions within some genomic regions implies recombination hot spots or a selective advantage for loss of particular sequence stretches.

This feature could provide an appreciable advantage for loss of function studies at late larval stages or even adult stages that cannot be easily achieved with morpholinos.

PMTCT programs can take advantage of loss aversion through the use of commitment contracts that incentivize mothers to return to the clinic in order to avoid both reputational and financial loss.

The expression of ASPP1 and ASPP2 is frequently downregulated in human breast tumours (Samuels-Lev et al, 2001) and tumour cell lines (Liu et al, 2005) expressing wild-type p53, suggesting that there is a selective advantage for loss of ASPP1 and ASPP2 expression in human breast tumours expressing wild-type p53.

The cluster/site approximation (CSA) offers computational advantages, without loss of accuracy, over the cluster variation method (CVM) in the calculation of multicomponent phase diagrams.